Statistics from Altmetric.com
Commentary on: OpenUrl.
Pharmacological management of heart rate, the mainstay of treatment in patients with atrial fibrillation (AF), is subjected to ongoing controversy.1 Two important questions yet to be answered in rate control therapy are; what constitutes the optimal heart rate during AF and which rate controlling drug should be instituted in the individual patient.
Optimal heart rate in AF has been studied in one large randomised trial, the Rate Control Efficacy in Permanent Atrial Fibrillation (RACE II) study, which compared lenient versus strict rate control. RACE II showed that a lenient approach to rate control is easy, safe and effective and should be considered as an initial approach for those with few symptoms.2 However, randomised controlled trials on …
Competing interests None declared.
Provenance and peer review Commissioned; internally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.